The still to be founded company with the project name RELF, intends to provide automated decision support tools for ongoing chest pain in patients with coronary artery disease. The Mini RELF device is a small autonomous electronic equipment intended for the capturing and uploading of 3-channel-ECG signals. A low power wireless Bluetooth connection is used for the real time uploading to a host computer (laptop, tablet, smart phone).
The RELF project is designed and initiated by Prof. Dr. Peter Gheeraert at the Department of Cardiology, Ghent University, Belgium. The project has started officially in 2014 and is sponsored by an internal budget from the Industrial Research Fund (IOF). The project has been recently validated in a multi-center clinical trial (results published in The Lancet Digital Health). Currently the project is in the phase of searching for investors to build a RELF device with a medical device classification.
First 3-6 months will mainly be spent on investment and company set up efforts (only part time effort). From then on company guidance and further business spread, allowing a smooth transition into corporate venturing in 2-3 years.
Extra soft skills: